Stay abreast of COVID-19 information and developments here
Provided by the South African National Department of Health
UNITEDHEALTH: AN ENVIABLE
TRACK RECORD OF GROWTH
UnitedHealth Group is a leading health insurer in the US, offering a wide variety of plans and services to group and individual customers nationwide. We recently included the share in our global equity portfolios – in our view, the group generates very attractive returns, and its economies of scale and market position should put it in a strong position to continue to reward shareholders.
UnitedHealth Group is the largest healthcare company in the US by revenue. Its UnitedHealthcare health benefits segment manages health maintenance organisation, preferred provider organisation and point-of-service plans, as well as Medicare and Medicaid, and supplemental vision and dental options. In addition, UnitedHealth’s Optum health services units Optum Health, Optum Insight and Optum Rx provide wellness and care management programmes, financial services, information technology solutions and pharmacy benefits management services to individuals and the healthcare industry.
UnitedHealth’s core business of health insurance has grown rapidly over the past 20 years through a combination of good organic growth (underlying health spend) and industry consolidation. Consolidation has helped to boost scale for the larger industry players and has seen the absorption of several non-profit providers, which have been the least disciplined from a price perspective.
In the US, most healthcare is sponsored by either employers or the government, the main government programmes being Medicare (mostly for the elderly) and Medicaid (for lower-income individuals).
UnitedHealthcare accounts for more than 55% of revenue and 48% of the group’s profit pool. Its largest business is the Employer and Individual unit, which serves more than 26.7 million members through its plans for students, families, individuals and businesses ranging from sole proprietorships to multinational enterprises. The Medicare and Retirement senior services unit is the second largest business, serving around 7.1 million people through its Medicare Advantage products. A smaller unit, Community and State, manages public Medicaid programmes for disabled and disadvantaged citizens.
The Optum side of the business is an important profit driver for UnitedHealth, making up 52% of the group’s profit pool. Revenue growth for Optum should be rapid over the next few years, buoyed by the insourcing of pharmacy benefit activities. Prescription drug revenues worldwide are predicted to grow rapidly over the coming years – according to leading consulting firm Data Bridge Market Research, the global prescription drugs market is expected to be worth US$1 892.9 billion by 2030 – and we anticipate that Optum will participate in this dynamic.
UnitedHealth has an enviable track record of consistent growth despite its shares being subject to notable headline risks due to the regulatory framework within which the group operates. This framework is designed to ensure that customers are provided adequate medical services while the companies offering these services don’t make superprofits.
Due to the significant barriers to entry for smaller players in this highly regulated industry, and because new capital entering the industry is limited, the returns on capital have been above 30% for companies like UnitedHealth. The biggest operators in the US health insurance industry take advantage of their economies of scale to provide both better pricing on their insurance policies and superior service delivery.
We believe the market continues to undervalue the strong cash flow and above-average growth prospects of UnitedHealth due to political headline risks, especially during election years, of which 2024 is one. Notwithstanding these risks, the group is targeting 6-8% revenue growth over the medium term and 13-16% earnings-per-share growth, including the positive impact of stock repurchase activities.
At the company’s annual investor day in November last year, it stated that ‘Optum Health expects to deliver consistent and durable growth in new and existing markets by offering integrated, comprehensive care and capabilities and accelerating our path to value-based care with an enduring focus on quality, affordability and service excellence. We expect to continue to deliver double-digit revenue growth on average and continue to target a long-term operating margin profile in the 8% to 10% range.’
In our view, UnitedHealth will experience short-term pressures on operating margins as:
In our models we assume operating margin compression in the core health benefits business, but this will stabilise by next year as pricing improves and enrolment numbers settle back into the 3-4% annual increase rate. We expect the company to execute on the range of forecasts it set out at the investor day.
UnitedHealth aligns with our investment philosophy at Sanlam Private Wealth of investing in high-quality companies with a leading market position at compelling valuations. Capital allocation is exemplary, with the group set to deploy capital through targeted acquisitions while seeking to maintain a market-leading dividend and ongoing share repurchase activity.
This is expected to contribute in the range of 3 to 5 percentage points to the annual earnings-per-share growth rate while offering an historic free cash flow yield of 5%. UnitedHealth anticipates that its business performance and capital deployment will yield a return on equity of 20% or higher – a level that in our view should lead to strong shareholder returns over time.
We constantly challenge the norm. Our investment process is a thorough and diligent one.
Michael York has spent 21 years in Investment Management.
Looking for a customised wealth plan? Leave your details and we’ll be in touch.
South Africa
South Africa Home Sanlam Investments Sanlam Private Wealth Glacier by Sanlam Sanlam BlueStarRest of Africa
Sanlam Namibia Sanlam Mozambique Sanlam Tanzania Sanlam Uganda Sanlam Swaziland Sanlam Kenya Sanlam Zambia Sanlam Private Wealth MauritiusGlobal
Global Investment SolutionsCopyright 2019 | All Rights Reserved by Sanlam Private Wealth | Terms of Use | Privacy Policy | Financial Advisory and Intermediary Services Act (FAIS) | Principles and Practices of Financial Management (PPFM). | Promotion of Access to Information Act (PAIA) | Conflicts of Interest Policy | Privacy Statement
Sanlam Private Wealth (Pty) Ltd, registration number 2000/023234/07, is a licensed Financial Services Provider (FSP 37473), a registered Credit Provider (NCRCP1867) and a member of the Johannesburg Stock Exchange (‘SPW’).
MANDATORY DISCLOSURE
All reasonable steps have been taken to ensure that the information on this website is accurate. The information does not constitute financial advice as contemplated in terms of FAIS. Professional financial advice should always be sought before making an investment decision.
INVESTMENT PORTFOLIOS
Participation in Sanlam Private Wealth Portfolios is a medium to long-term investment. The value of portfolios is subject to fluctuation and past performance is not a guide to future performance. Calculations are based on a lump sum investment with gross income reinvested on the ex-dividend date. The net of fee calculation assumes a 1.15% annual management charge and total trading costs of 1% (both inclusive of VAT) on the actual portfolio turnover. Actual investment performance will differ based on the fees applicable, the actual investment date and the date of reinvestment of income. A schedule of fees and maximum commissions is available upon request.
COLLECTIVE INVESTMENT SCHEMES
The Sanlam Group is a full member of the Association for Savings and Investment SA. Collective investment schemes are generally medium to long-term investments. Past performance is not a guide to future performance, and the value of investments / units / unit trusts may go down as well as up. A schedule of fees and charges and maximum commissions is available on request from the manager, Sanlam Collective Investments (RF) Pty Ltd, a registered and approved manager in collective investment schemes in securities (‘Manager’).
Collective investments are traded at ruling prices and can engage in borrowing and scrip lending. The manager does not provide any guarantee either with respect to the capital or the return of a portfolio. Collective investments are calculated on a net asset value basis, which is the total market value of all assets in a portfolio including any income accruals and less any deductible expenses such as audit fees, brokerage and service fees. Actual investment performance of a portfolio and an investor will differ depending on the initial fees applicable, the actual investment date, date of reinvestment of income and dividend withholding tax. Forward pricing is used.
The performance of portfolios depend on the underlying assets and variable market factors. Performance is based on NAV to NAV calculations with income reinvestments done on the ex-dividend date. Portfolios may invest in other unit trusts which levy their own fees and may result is a higher fee structure for Sanlam Private Wealth’s portfolios.
All portfolio options presented are approved collective investment schemes in terms of Collective Investment Schemes Control Act, No. 45 of 2002. Funds may from time to time invest in foreign countries and may have risks regarding liquidity, the repatriation of funds, political and macroeconomic situations, foreign exchange, tax, settlement, and the availability of information. The manager may close any portfolio to new investors in order to ensure efficient management according to applicable mandates.
The management of portfolios may be outsourced to financial services providers authorised in terms of FAIS.
TREATING CUSTOMERS FAIRLY (TCF)
As a business, Sanlam Private Wealth is committed to the principles of TCF, practicing a specific business philosophy that is based on client-centricity and treating customers fairly. Clients can be confident that TCF is central to what Sanlam Private Wealth does and can be reassured that Sanlam Private Wealth has a holistic wealth management product offering that is tailored to clients’ needs, and service that is of a professional standard.